Page 1317 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

2 References

purpura-hemolytic uremic syndrome: all patients, idiopathic 44. Bennett CL, Kim B, Zakarija A, et al. Two mechanistic pathways
patients, and patients with severe ADAMTS13 deficiency. for thienopyridine-associated thrombotic thrombocytopenic
J Thromb Haemost. 2005;3(7):1432-1436. purpura: a report from the SERF-TTP Research Group and the
29. Furlan M, Robles R, Solenthaler M, Lammle B. Acquired RADAR Project. J Am Coll Cardiol. 2007;50(12):1138-1143.
deficiency of von Willebrand factor-cleaving protease in a 45. Shelat SG, Smith AG, Ai J, Zheng X.L. Inhibitory autoantibodies
patient with thrombotic thrombocytopenic purpura. Blood. against ADAMTS13 in patients with thrombotic thrombocyto-
1998;91(8):2839-2846. penic purpura bind ADAMTS13 protease and may accelerate its
30. Gungor T, Furlan M, Lammle B, Kuhn F, Seger RA. Acquired clearance in vivo. J Thromb Haemost. 2006;4:1707-1717.
deficiency of von Willebrand factor-cleaving protease in a 46. Zheng XL, Sadler JE. Thrombotic thrombocytopenic purpura
patient suffering from acute systemic lupus erythematosus. and hemolytic uremic syndrome. In: Young NS, Gerson SL,
Rheumatology (Oxford). 2001;40(8):940-942. High KA, eds. Clinical Hematology. Philadelphia, PA: Mosby
31. Leaf AN, Laubenstein LJ, Raphael B, Hochster H, Baez L, Elsevier; 2006:802-813.
Karpatkin S. Thrombotic thrombocytopenic purpura associated 47. George JN. How I treat patients with thrombotic throm-
with human immunodeficiency virus type 1 (HIV-1) infection. bocytopenic purpura-hemolytic uremic syndrome. Blood.
Ann Intern Med. 1988;109(3):194-197. 2000;96(4):1223-1229.
32. Bar Meir E, Amital H, Levy Y, Kneller A, Bar-Dayan Y, 48. George JN, Selby GB. Thrombotic microangiopathy after allo-
Shoenfeld Y. Mycoplasma-pneumoniae-induced thrombotic geneic bone marrow transplantation: a pathologic abnormal-
thrombocytopenic purpura. Acta Haematol. 2000;103(2): ity associated with diverse clinical syndromes. Bone Marrow
112-115. Transplant. 2004;33(11):1073-1074.
33. Niv E, Segev A, Ellis MH. Staphylococcus aureus bacteremia 49. George JN, Li X, McMinn JR, Terrell DR, Vesely SK, Selby GB.
as a cause of early relapse of thrombotic thrombocytopenic Thrombotic thrombocytopenic purpura-hemolytic uremic syn-
purpura. Transfusion. 2000;40(9):1067-1070. drome following allogeneic HPC transplantation: a diagnostic
34. Holler E, Kolb HJ, Hiller E, et al. Microangiopathy in patients dilemma. Transfusion. 2004;44(2):294-304.
on cyclosporine prophylaxis who developed acute graft-versus- 50. Bell WR, Braine HG, Ness PM, Kickler TS. Improved survival
host disease after HLA-identical bone marrow transplantation. in thrombotic thrombocytopenic purpura-hemolytic uremic
Blood. 1989;73(7):2018-2024. syndrome. Clinical experience in 108 patients. N Engl J Med.
35. Gharpure VS, Devine SM, Holland HK, Geller RB, O’Toole K, 1991;325(6):398-403.
Wingard JR. Thrombotic thrombocytopenic purpura associ- 51. Hovinga JA, Vesely SK, Terrell DR, Lammle B, George JN.
ated with FK506 following bone marrow transplantation. Bone Survival and relapse in patients with thrombotic thrombocyto-
Marrow Transplant. 1995;16(5):715-716. penic purpura. Blood. 2010;115(8):1500-1511.
36. Moake JL, Byrnes JJ. Thrombotic microangiopathies associated 52. Rock GA, Shumak KH, Buskard NA, et al. Comparison of
with drugs and bone marrow transplantation. Hematol Oncol plasma exchange with plasma infusion in the treatment of
Clin North Am. 1996;10(2):485-497. thrombotic thrombocytopenic purpura. Canadian Apheresis
37. Fontana S, Gerritsen HE, Kremer Hovinga J, Furlan M, Lammle Study Group. N Engl J Med. 1991;325(6):393-397.
B. Microangiopathic haemolytic anaemia in metastasizing 53. Zheng XL, Richard KM, Goodnough LT, Sadler JE. Effect
malignant tumours is not associated with a severe deficiency of plasma exchange on plasma ADAMTS13 metalloprotease
of the von Willebrand factor-cleaving protease. Br J Haematol. activity, inhibitor level, and clinical outcome in patients with
2001;113(1):100-102. idiopathic and non-idiopathic thrombotic thrombocytopenic
38. Gordon LI, Kwaan HC. Thrombotic microangiopathy mani- purpura. Blood. 2004;103(11):4043-4049.
festing as thrombotic thrombocytopenic purpura/hemolytic 54. Sarode R, McFarland JG, Flomenberg N, et al. Therapeutic
uremic syndrome in the cancer patient. Semin Thromb Hemost. plasma exchange does not appear to be effective in the man-
1999;25(2):217-221. agement of thrombotic thrombocytopenic purpura/hemolytic
39. Ravandi-Kashani F, Cortes J, Talpaz M, Kantarjian HM. uremic syndrome following bone marrow transplantation. Bone
Thrombotic microangiopathy associated with interferon therapy Marrow Transplant. 1995;16(2):271-275.
for patients with chronic myelogenous leukemia: coincidence or 55. Loirat C, Sonsino E, Varga Moreno A, et al. Hemolytic-uremic
true side effect? Cancer. 1999;85(12):2583-2588. syndrome: an analysis of the natural history and prognostic
40. Durand JM, Lefevre P. Mitomycin-induced thrombotic features. Acta Paediatr Scand. 1984;73(4):505-514.
thrombocytopenic purpura: possible successful treatment 56. Scheiring J, Andreoli SP, Zimmerhackl LB. Treatment and
with vincristine and cyclophosphamide. Haematologica. outcome of Shiga-toxin-associated hemolytic uremic syndrome
1991;76(5):421-423. (HUS). Pediatr Nephrol. 2008;23(10):1749-1760.
41. Medina PJ, Sipols JM, George JN. Drug-associated thrombotic 57. Tarr PI, Neill MA, Clausen CR, Watkins SL, Christie DL,
thrombocytopenic purpura-hemolytic uremic syndrome. Curr Hickman RO. Escherichia coli O157:H7 and the hemolytic ure-
Opin Hematol. 2001;8(5):286-293. mic syndrome: importance of early cultures in establishing the
42. Muszkat M, Shapira MY, Sviri S, Linton DM, Caraco Y. etiology. J Infect Dis. 1990;162(2):553-556.
Ticlopidine-induced thrombotic thrombocytopenic purpura. 58. Tarr PI. Escherichia coli O157:H7: clinical, diagnostic, and
Pharmacotherapy. 1998;18(6):1352-1355. epidemiological aspects of human infection. Clin Infect Dis.
43. Bennett CL, Connors JM, Carwile JM, et al. Thrombotic throm- 1995;20(1):1-8.
bocytopenic purpura associated with clopidogrel. N Engl J Med. 59. Rowe PC, Orrbine E, Lior H, et al. Risk of hemolytic uremic syn-
2000;342(24):1773-1777. drome after sporadic Escherichia coli O157:H7 infection: results

Section07-O-ref.indd 2 1/21/2015 11:26:48 AM